Most Accessed Articles

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

, 2016; 3(2): 131-137.

G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken

DOI: 10.2174/2212697X03666160610085943

Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy

, 2015; 2(1): 61-70.

Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger

DOI: 10.2174/2212697X02666150331202809

Prostate Cancer Molecular Background: The IGF-1Ec Story

, 2016; 3(1): 6-15.

Armakolas Athanasios and Koutsilieris Michael

DOI: 10.2174/2212697X03666151203202720

Book Review: Handbook of Melanoma Edited by Jonathan S. Zager, Vernon K. Sondak, and Ragini Kudchadkar

, 2017; 4(2): 150-150.

Feng Liang

DOI: 10.2174/2212697X0402180109171607

Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

, 2015; 2(1): 54-60.

Koichi Momiyama, Hidenari Nagai, Yu Ogino, Takanori Mukozu, Daigo Matsui, Teppei Matsui, Noritaka Wakui, Mie Shinohara, Yoshinori Igarashi and Yasukiyo Sumino

DOI: 10.2174/2212697X02666150313003755

Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer

, 2016; 3(1): 23-35.

Lavinia Casati, Fabio Celotti and Valeria Sibilia

DOI: 10.2174/2212697X03666151207185452

Molecular Fundamentals and Rationale for Immunotherapy in Metastatic Melanoma Treatment

, 2015; 2(1): 4-15.

Mizue Terai and Takami Sato

DOI: 10.2174/2212697X02666150203212041

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

, 2016; 3(1): 36-62.

Festuccia Claudio

DOI: 10.2174/2212697X0301160328201324

Webmaster Contact:
Copyright © 2018 Bentham Science